subject: Pharmaceutical industry mergers and acquisitions to become the general trend - Restructuring - pharmaceutical industries [print this page] Pharmaceutical industry mergers and acquisitions to become the general trend - Restructuring - pharmaceutical industries
"With the basic medical and health services, essential drugs and gradually covering urban and rural residents, Medicine A sharp increase in the total health needs, drug structure and Drugs Supply channels will undergo major changes, industry mergers and acquisitions to become the general trend. "
Yesterday, held in Beijing "2010 China Food Drug Administration will ", the State Food and Drug Administration (SFDA) Shao Mingli pharmaceutical industry this year to the forecast.
This judge, the "combination of Essential drugs system The implementation of resources to promote the integration of pharmaceutical operations, merger and reorganization, survival of the fittest, the promotion of pharmaceutical development of modern logistics, ensuring timely distribution of essential medicines, "the emphasis has clearly written SFDA this year's work plan.
This process, for new drug retail, wholesale, pharmaceutical companies and other commercial enterprises will be the first face to be "elevated" threshold.
Chinese Medicine [28.983.72%] Enterprise Management Association in Matilda accept the "Business News" interview that, following the reorganization Sinopharm Health Group, the White House and on Biomedical Engineering, Shanghai Pharmaceutical Medicine 2009 restructuring After the acquisition of a large event production company, pharmaceutical business merger and reorganization of enterprises will be eye-catching performance in 2010.
He pointed out that the provincial system of essential drugs Tender Raised to varying degrees, the requirements of the pharmaceutical business enterprises, large business enterprises to obtain a policy tilt the pressure many small and medium business enterprises great. Second half of 2009 to improve efficiency, reduce costs for the purpose of mergers and acquisitions and business alliances in large numbers, will likely change the current pattern of Chinese commercial enterprises.
At the same time, because five years ago, the first certified GSP (GoodSupplyPractice, a good supply of standard) one after another due in 2009, 2010, most Chinese business enterprises also have to face GSP re-certification "pass."
Reporter learned from the conference in 2010, the revised GSP aimed against the once rapid growth of retail, and wholesale enterprises, enterprises must be certified to increase investment in hardware and software?? SFDA relevant responsible person will be held at clearly pointed out: "To enhance the technical requirements and barriers to entry, determined to contain pharmaceutical wholesale, retail businesses too much too fast growth momentum, leading pharmaceutical trading enterprises to scale, modernization of the road; should establish a high threshold for new businesses, specified in the direction of development of existing enterprises. "
Industry expects a new round of certification in the industry reshuffle, will appear, Guantingbingzhuan competitive situation, the pharmaceutical business of concentration will be improved rapidly.
In addition, the date of the meeting said, SFDA is studying the construction of rural drug supply network policies, specific measures will be introduced to guide the scale of wholesale enterprises extend to rural areas, rural pharmaceutical distribution enterprise with organic link, to ensure effective development in rural areas the supply of drugs network.
If and so, in The new medical reform And rural areas, "Two Networks", led by Nanjing Medical [10.303.94%] (600713.SH), Huaihai medicine area represented a strong, characteristic commercial companies, will be more consolidation opportunities.
According to statistics of China Association of Chinese business, China's first three Chinese commercial enterprises Sinopharm [31.150.00%] (01099.HK), Shanghai Traditional Chinese Medicine [15.401.78%] (600849.SH), Kyushu Dhongcherm Medicine market Sell Increases for the proportion of the amount, from 19.2% in 2007 to 20.1% in 2008.
